Proactive Investors - Run By Investors For Investors

NMC Health notches up bumper year as acquisition spree continues

Over a third of its licensed bed capacity is in Saudi Arabia
Surgery
NMC operates in 13 countries

Middle East-focused hospital operator group NMC Health plc (LON:NMC) lifted revenues by a third and predicted another strong year ahead as more sites come on stream.

“Sustained ramp-up of utilisation at facilities we opened in recent years, integration of acquired assets and continued discipline in organic and inorganic expansions should all translate into a very promising 2018 and beyond,” said Prasanth Manghat, chief executive.

“The most important assets to keep a track of in this regard are: NMC Royal, Brightpoint and Chronic Care for ramp-up of operations, Al Zahra Hospital and CosmeSurge from an integration standpoint and the GCC [Gulf Co-operation Council] in general and KSA [Saudi Arabia] in particular for additional acquisitions as we continue to see the benefit from acquiring assets and optimising their capabilities within the NMC network/model.”

READ: FTSE 100 stocks you should have bet your house on in 2017

NMC operates 125 hospitals and clinics across 13 countries and is also one of the world’s top 3 in-vitro fertilisation operators. Over a third of its licensed bed capacity is in Saudi Arabia.

Sales at the FTSE 100 group rose to US$1.6bn (US$1.22bn) in the year to December, while underlying profits [EBITDA] rose 43% to US$353mln.

The dividend rises by 20% to 13p.

Shares eased 2.6% to 3,272p.

View full NMC profile View Profile

NMC Health plc Timeline

Related Articles

cannabis
October 18 2018
Sativa Investments has taken a big step towards becoming the UK's first seed to consumer medicinal cannabis business
cholesterol on a dial
September 24 2018
"The formation of ProBiotix Health and appointment of Adam Reynolds as chairman continues a successful strategy of building value in each division which is materialised by forming separate legal entities and taking them to a public listing,” said chief executive Stephen O’Hara
CBD oil
November 15 2018
The company’s technology creates nano-scale emulsion mixtures that allow fluids to mix that normally don’t mix, such as CBD oil and water

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use